FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017757660> ?p ?o ?g. }

• W2017757660 endingPage "1425" @default.
• W2017757660 startingPage "1419" @default.
• W2017757660 abstract "Background: Recombinant activated coagulation factor VII (rFVIIa) is increasingly being administered to massively bleeding trauma patients. rFVIIa has been shown to correct coagulopathy and to decrease transfusion requirements. However, there is no conclusive evidence to suggest that rFVIIa improves the survival of these patients. The purpose of this study was to determine whether or not rFVIIa has an effect on the in-hospital survival of massively bleeding trauma patients. Methods: A retrospective cohort study was conducted from January 1, 2000 to January 31, 2005, at a Level I trauma center in Toronto, Canada. Inclusion criteria included trauma patients requiring transfusion of 8 or more units of packed red cells within the first 12 hours of admission. The primary exposure of interest was the administration of rFVIIa. Primary outcome was a 24-hour survival and secondary outcome was overall in-hospital survival. Results: There were 242 trauma patients identified who met inclusion criteria; 38 received rFVIIa. rFVIIa patients were younger, had more penetrating injuries, and fewer head injuries. However, rFVIIa patients required more red cell transfusions initially, and were more acidotic. Administering rFVIIa was associated with improved 24-hour survival, after adjusting for baseline demographics and injury factors. The odds ratio (OR) for survival was 3.4 (1.2–9.8). Furthermore, there was a strong trend toward increased overall in-hospital survival. The OR of in-hospital survival was 2.5 (0.8–7.6). Also, subgroup analysis of rFVIIa patients showed that 24-hour survivors required a slower initial rate of red cell transfusion (4.5 vs. 2.9 units/hr, p = 0.002), had higher platelet counts (175 vs. 121 [×10−9/L], p = 0.05) and smaller base deficits (7.1 vs. 14.3, p = 0.001) compared with rFVIIa patients who died during the first 24 hours. Conclusion: rFVIIa may be able to improve the early survival of massively bleeding trauma patients. However, surgical control of massive hemorrhage still has primacy, as rFVIIa did not appear efficacious if extremely high red cell transfusion rates were required. Also, correction of acidosis and thrombocytopenia may be important for rFVIIa efficacy. Prospective studies are required." @default.
• W2017757660 created "2016-06-24" @default.
• W2017757660 creator A5004406373 @default.
• W2017757660 creator A5015063439 @default.
• W2017757660 creator A5015950115 @default.
• W2017757660 creator A5026483486 @default.
• W2017757660 creator A5028848754 @default.
• W2017757660 creator A5054314550 @default.
• W2017757660 creator A5064010012 @default.
• W2017757660 creator A5077729653 @default.
• W2017757660 creator A5085744395 @default.
• W2017757660 date "2006-12-01" @default.
• W2017757660 modified "2023-10-12" @default.
• W2017757660 title "Recombinant Activated Coagulation Factor VII and Bleeding Trauma Patients" @default.
• W2017757660 cites W1573466087 @default.
• W2017757660 cites W1973511791 @default.
• W2017757660 cites W1990180140 @default.
• W2017757660 cites W2011356417 @default.
• W2017757660 cites W2011659354 @default.
• W2017757660 cites W2013828405 @default.
• W2017757660 cites W2025818308 @default.
• W2017757660 cites W2032406032 @default.
• W2017757660 cites W2033068103 @default.
• W2017757660 cites W2046936517 @default.
• W2017757660 cites W2048378282 @default.
• W2017757660 cites W2053350211 @default.
• W2017757660 cites W2063038576 @default.
• W2017757660 cites W2066317661 @default.
• W2017757660 cites W2069798347 @default.
• W2017757660 cites W2084006599 @default.
• W2017757660 cites W2085970489 @default.
• W2017757660 cites W2087501885 @default.
• W2017757660 cites W2091685079 @default.
• W2017757660 cites W2117437723 @default.
• W2017757660 cites W2122643422 @default.
• W2017757660 cites W2134658561 @default.
• W2017757660 cites W2140699529 @default.
• W2017757660 cites W2149106614 @default.
• W2017757660 cites W2151327456 @default.
• W2017757660 cites W2161715292 @default.
• W2017757660 cites W2165755420 @default.
• W2017757660 cites W2399820111 @default.
• W2017757660 cites W4238103798 @default.
• W2017757660 cites W4248590026 @default.
• W2017757660 cites W4254117192 @default.
• W2017757660 cites W4376542775 @default.
• W2017757660 doi "https://doi.org/10.1097/01.ta.0000243045.56579.74" @default.
• W2017757660 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17159685" @default.
• W2017757660 hasPublicationYear "2006" @default.
• W2017757660 type Work @default.
• W2017757660 sameAs 2017757660 @default.
• W2017757660 citedByCount "73" @default.
• W2017757660 countsByYear W20177576602012 @default.
• W2017757660 countsByYear W20177576602013 @default.
• W2017757660 countsByYear W20177576602015 @default.
• W2017757660 countsByYear W20177576602016 @default.
• W2017757660 countsByYear W20177576602017 @default.
• W2017757660 countsByYear W20177576602018 @default.
• W2017757660 crossrefType "journal-article" @default.
• W2017757660 hasAuthorship W2017757660A5004406373 @default.
• W2017757660 hasAuthorship W2017757660A5015063439 @default.
• W2017757660 hasAuthorship W2017757660A5015950115 @default.
• W2017757660 hasAuthorship W2017757660A5026483486 @default.
• W2017757660 hasAuthorship W2017757660A5028848754 @default.
• W2017757660 hasAuthorship W2017757660A5054314550 @default.
• W2017757660 hasAuthorship W2017757660A5064010012 @default.
• W2017757660 hasAuthorship W2017757660A5077729653 @default.
• W2017757660 hasAuthorship W2017757660A5085744395 @default.
• W2017757660 hasConcept C126322002 @default.
• W2017757660 hasConcept C141071460 @default.
• W2017757660 hasConcept C156957248 @default.
• W2017757660 hasConcept C167135981 @default.
• W2017757660 hasConcept C2776283816 @default.
• W2017757660 hasConcept C2779936836 @default.
• W2017757660 hasConcept C2780110798 @default.
• W2017757660 hasConcept C42219234 @default.
• W2017757660 hasConcept C71924100 @default.
• W2017757660 hasConceptScore W2017757660C126322002 @default.
• W2017757660 hasConceptScore W2017757660C141071460 @default.
• W2017757660 hasConceptScore W2017757660C156957248 @default.
• W2017757660 hasConceptScore W2017757660C167135981 @default.
• W2017757660 hasConceptScore W2017757660C2776283816 @default.
• W2017757660 hasConceptScore W2017757660C2779936836 @default.
• W2017757660 hasConceptScore W2017757660C2780110798 @default.
• W2017757660 hasConceptScore W2017757660C42219234 @default.
• W2017757660 hasConceptScore W2017757660C71924100 @default.
• W2017757660 hasIssue "6" @default.
• W2017757660 hasLocation W20177576601 @default.
• W2017757660 hasLocation W20177576602 @default.
• W2017757660 hasOpenAccess W2017757660 @default.
• W2017757660 hasPrimaryLocation W20177576601 @default.
• W2017757660 hasRelatedWork W143978799 @default.
• W2017757660 hasRelatedWork W1710033904 @default.
• W2017757660 hasRelatedWork W1992034786 @default.
• W2017757660 hasRelatedWork W2072208391 @default.
• W2017757660 hasRelatedWork W2160768287 @default.
• W2017757660 hasRelatedWork W2322895208 @default.
• W2017757660 hasRelatedWork W2768980351 @default.

• next